Sacco, Simona
Di Ciaccio, Sonia
Di Virgilio, Roberto
Pegoraro, Valeria http://orcid.org/0000-0003-2359-6380
Ornello, Raffaele
Funding for this research was provided by:
Pfizer S.r.l.
Article History
Received: 23 January 2024
Accepted: 22 March 2024
First Online: 27 March 2024
Declarations
:
: IQVIA LPD data relies on anonymous data which are not originated by any clinical trial. A non-identifiable encryption process guarantee data are anonymized before being stored into IQVIA databases, directly on GPs’ computer. IQVIA LPD complies with the European Regulation 679/2016 and the ex-Legislative Decree 196/03 and subsequent modifications, and all the analyses using IQVIA LPD data do not require any Ethical Committee’s approval.
: S.D.C. and R.D.V. have disclosed that they are employees of Pfizer Srl. V.P. has disclosed that she is an employee of IQVIA. S.S.: personal fees as speaker or advisor (Abbott, Allergan-Abbvie, AstraZeneca, Boheringer, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva); research grants (Novartis, Uriach); intellectual (president elect European Stroke Organization, second vice president of the European Headache Federation, specialty chief editor in Headache and Neurogenic Pain for Frontiers in Neurology, associate editor for The Journal of Headache and Pain, assistant editor for Stroke). R.O.: personal fees as speaker or advisor (Allergan-AbbVie, Eli Lilly, Novartis, Pfizer, Teva); research grants (Novartis); intellectual (Associate Editor in Headache and Neurogenic Pain for Frontiers in Neurology, Junior Editorial Board Member for The Journal of Headache and Pain).